BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24912015)

  • 1. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
    Bhateria M; Rachumallu R; Singh R; Bhatta RS
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte-inspired delivery systems.
    Hu CM; Fang RH; Zhang L
    Adv Healthc Mater; 2012 Sep; 1(5):537-47. PubMed ID: 23184788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-modified loaded human red blood cells for targeting and delivery of drugs.
    Sternberg N; Georgieva R; Duft K; Bäumler H
    J Microencapsul; 2012; 29(1):9-20. PubMed ID: 22034952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Blood Cells as Smart Delivery Systems.
    Han X; Wang C; Liu Z
    Bioconjug Chem; 2018 Apr; 29(4):852-860. PubMed ID: 29298380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
    Glassman PM; Hood ED; Ferguson LT; Zhao Z; Siegel DL; Mitragotri S; Brenner JS; Muzykantov VR
    Adv Drug Deliv Rev; 2021 Nov; 178():113992. PubMed ID: 34597748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
    Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
    ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells.
    Pan D; Vargas-Morales O; Zern B; Anselmo AC; Gupta V; Zakrewsky M; Mitragotri S; Muzykantov V
    PLoS One; 2016; 11(3):e0152074. PubMed ID: 27003833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes.
    Chambers E; Mitragotri S
    J Control Release; 2004 Nov; 100(1):111-9. PubMed ID: 15491815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery by erythrocytes: "Primum non nocere".
    Villa CH; Seghatchian J; Muzykantov V
    Transfus Apher Sci; 2016 Dec; 55(3):275-280. PubMed ID: 27856317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles disguised as red blood cells to evade the immune system.
    Fang RH; Hu CM; Zhang L
    Expert Opin Biol Ther; 2012 Apr; 12(4):385-9. PubMed ID: 22332936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomes composed of unsaturated lipids for membrane modification of human erythrocytes.
    Stoll C; Holovati JL; Acker JP; Wolkers WF
    Mol Membr Biol; 2011; 28(7-8):454-61. PubMed ID: 21954868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells.
    Pan DC; Myerson JW; Brenner JS; Patel PN; Anselmo AC; Mitragotri S; Muzykantov V
    Sci Rep; 2018 Jan; 8(1):1615. PubMed ID: 29371620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel engineering: Biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery.
    Izzati Mat Rani NN; Alzubaidi ZM; Azhari H; Mustapa F; Iqbal Mohd Amin MC
    Eur J Pharmacol; 2021 Jun; 900():174009. PubMed ID: 33722591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cells and polyelectrolyte multilayer capsules: natural carriers versus polymer-based drug delivery vehicles.
    Kolesnikova TA; Skirtach AG; Möhwald H
    Expert Opin Drug Deliv; 2013 Jan; 10(1):47-58. PubMed ID: 23078091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery carriers on the fringes: natural red blood cells versus synthetic multilayered capsules.
    Muzykantov VR
    Expert Opin Drug Deliv; 2013 Jan; 10(1):1-4. PubMed ID: 23176316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
    Villa CH; Anselmo AC; Mitragotri S; Muzykantov V
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):88-103. PubMed ID: 26941164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human erythrocytes as drug carriers: loading efficiency and side effects of hypotonic dialysis, chlorpromazine treatment and fusion with liposomes.
    Favretto ME; Cluitmans JC; Bosman GJ; Brock R
    J Control Release; 2013 Sep; 170(3):343-51. PubMed ID: 23747798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.
    Zhang E; Phan P; Algarni HA; Zhao Z
    Pharm Res; 2022 Nov; 39(11):2673-2698. PubMed ID: 35794397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.
    Villa CH; Cines DB; Siegel DL; Muzykantov V
    Transfus Med Rev; 2017 Jan; 31(1):26-35. PubMed ID: 27707522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical progress and advanced research of red blood cells based drug delivery system.
    Li Y; Raza F; Liu Y; Wei Y; Rong R; Zheng M; Yuan W; Su J; Qiu M; Li Y; Raza F; Liu Y; Wei Y; Rong R; Zheng M; Yuan W; Su J; Qiu M
    Biomaterials; 2021 Dec; 279():121202. PubMed ID: 34749072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.